# Ginkgo Bioworks Holdings, Inc.: filings

DNA · NYSE · CIK 1830214 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dna.md) · [Financials](/companies/dna/financials.md) · [Filings](/companies/dna/filings.md) · [Insiders](/companies/dna/insiders.md)

## Reports and events: 120 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (144 740, 4 443, 8-K 64, 425 43, 424B3 28, 3 27, SC 13G/A 25, EFFECT 22, CORRESP 21, UPLOAD 18, 10-Q 17, SC 13G 12, POS AM 10, S-1/A 8, SC 13D/A 8, SCHEDULE 13G/A 7, DEF 14A 6, S-8 6, 10-K 5, DEFA14A 5, S-1 5, S-3 5, S-4/A 5, ARS 4, 424B5 3, 4/A 3, SC 13D 3, 144/A 2, 8-A12B 2, 8-K/A 2, CERT 2, S-4 2, SEC STAFF LETTER 2, 10-K/A 1, 25 1, 25-NSE 1, 3/A 1, 424B4 1, DRS 1, DRS/A 1, DRSLTR 1, NT 10-K 1, NT 10-Q 1, PRE 14A 1, PRER14A 1, SCHEDULE 13D/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 16:09 ET | [10-Q](/filings/0001628280-26-054298.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054298 |
| 2026-08-05 | 16:06 ET | [8-K](/filings/0001628280-26-053319.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053319 |
| 2026-07-30 | 16:06 ET | [8-K](/filings/0001628280-26-051041.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-051041 |
| 2026-06-12 | 17:00 ET | [8-K](/filings/0001628280-26-042932.md) | 5.07 Shareholder vote results | 0001628280-26-042932 |
| 2026-05-07 | 16:13 ET | [10-Q](/filings/0001628280-26-032116.md) | Quarterly report, period 2026-03-31 | 0001628280-26-032116 |
| 2026-05-07 | 16:09 ET | [8-K](/filings/0001628280-26-032093.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-032093 |
| 2026-04-29 | 16:10 ET | [DEF 14A](/filings/0001628280-26-028377.md) | Proxy statement, period 2026-06-11 | 0001628280-26-028377 |
| 2026-04-07 | 17:02 ET | [8-K](/filings/0001628280-26-024101.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001628280-26-024101 |
| 2026-02-27 | 21:56 ET | [8-K](/filings/0001628280-26-012552.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-26-012552 |
| 2026-02-26 | 16:34 ET | [10-K](/filings/0001628280-26-012346.md) | Annual report, period 2025-12-31 | 0001628280-26-012346 |
| 2026-02-26 | 16:30 ET | [8-K](/filings/0001628280-26-012339.md) | 2.02 Results of operations | 0001628280-26-012339 |
| 2025-12-23 | 17:26 ET | [8-K](/filings/0001628280-25-058791.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001628280-25-058791 |
| 2025-11-06 | 16:17 ET | [10-Q](/filings/0001628280-25-050193.md) | Quarterly report, period 2025-09-30 | 0001628280-25-050193 |
| 2025-11-06 | 16:10 ET | [8-K](/filings/0001830214-25-000013.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001830214-25-000013 |
| 2025-09-04 | 16:57 ET | [8-K](/filings/0001830214-25-000009.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001830214-25-000009 |
| 2025-08-29 | 16:07 ET | [8-K](/filings/0001628280-25-041399.md) | 8.01 Other events | 0001628280-25-041399 |
| 2025-08-07 | 17:05 ET | [10-Q](/filings/0001628280-25-038982.md) | Quarterly report, period 2025-06-30 | 0001628280-25-038982 |
| 2025-08-07 | 17:03 ET | [8-K](/filings/0001628280-25-038981.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-038981 |
| 2025-06-13 | 16:06 ET | [8-K](/filings/0001628280-25-031304.md) | 5.07 Shareholder vote results | 0001628280-25-031304 |
| 2025-05-21 | 16:07 ET | [8-K](/filings/0001628280-25-027058.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-027058 |
| 2025-05-06 | 17:04 ET | [10-Q](/filings/0001628280-25-022761.md) | Quarterly report, period 2025-03-31 | 0001628280-25-022761 |
| 2025-05-06 | 17:03 ET | [8-K](/filings/0001628280-25-022759.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-022759 |
| 2025-04-29 | 16:01 ET | [DEF 14A](/filings/0001628280-25-020648.md) | Proxy statement, period 2025-06-12 | 0001628280-25-020648 |
| 2025-02-25 | 17:05 ET | [10-K](/filings/0001628280-25-007819.md) | Annual report, period 2024-12-31 | 0001628280-25-007819 |
| 2025-02-25 | 17:02 ET | [8-K](/filings/0001628280-25-007816.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-007816 |
| 2025-02-14 | 16:03 ET | [SCHEDULE 13D/A](/filings/0001628280-25-005686.md) | Ownership report, active investor, amended | 0001628280-25-005686 |
| 2024-11-12 | 17:05 ET | [10-Q](/filings/0001628280-24-047284.md) | Quarterly report, period 2024-09-30 | 0001628280-24-047284 |
| 2024-11-12 | 17:03 ET | [8-K](/filings/0001628280-24-047276.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-047276 |
| 2024-09-04 | 16:42 ET | [8-K](/filings/0001628280-24-039341.md) | 3.01 Delisting notice; 8.01 Other events | 0001628280-24-039341 |
| 2024-08-19 | 16:06 ET | [8-K](/filings/0001628280-24-037685.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001628280-24-037685 |
| 2024-08-15 | 16:04 ET | [8-K](/filings/0001628280-24-037384.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001628280-24-037384 |
| 2024-08-08 | 17:06 ET | [10-Q](/filings/0001628280-24-036231.md) | Quarterly report, period 2024-06-30 | 0001628280-24-036231 |
| 2024-08-08 | 17:03 ET | [8-K/A](/filings/0001628280-24-036226.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001628280-24-036226 |
| 2024-07-05 | 17:18 ET | [DEF 14A](/filings/0001628280-24-031299.md) | Proxy statement, period 2024-08-14 | 0001628280-24-031299 |
| 2024-06-24 | 17:16 ET | [8-K/A](/filings/0001628280-24-029635.md) | 2.05 Exit or disposal costs | 0001628280-24-029635 |
| 2024-06-14 | 16:07 ET | [8-K](/filings/0001628280-24-028287.md) | 5.07 Shareholder vote results | 0001628280-24-028287 |
| 2024-05-13 | 16:14 ET | [8-K](/filings/0001628280-24-022896.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-022896 |
| 2024-05-09 | 16:11 ET | [10-Q](/filings/0001628280-24-022229.md) | Quarterly report, period 2024-03-31 | 0001628280-24-022229 |
| 2024-05-09 | 16:02 ET | [8-K](/filings/0001628280-24-022191.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001628280-24-022191 |
| 2024-04-29 | 16:01 ET | [DEF 14A](/filings/0001628280-24-018970.md) | Proxy statement, period 2024-06-13 | 0001628280-24-018970 |
| 2024-03-14 | 16:07 ET | [8-K](/filings/0001628280-24-011216.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001628280-24-011216 |
| 2024-02-29 | 17:07 ET | [10-K](/filings/0001628280-24-008052.md) | Annual report, period 2023-12-31 | 0001628280-24-008052 |
| 2024-02-29 | 17:03 ET | [8-K](/filings/0001628280-24-008045.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-008045 |
| 2024-02-14 | 17:05 ET | [SC 13D/A](/filings/0001628280-24-004834.md) | Ownership report, active investor, amended | 0001628280-24-004834 |
| 2024-02-14 | 17:03 ET | [SC 13D/A](/filings/0001628280-24-004831.md) | Ownership report, active investor, amended | 0001628280-24-004831 |
| 2024-01-10 | 07:37 ET | [8-K](/filings/0001628280-24-001000.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-001000 |
| 2023-11-08 | 17:06 ET | [10-Q](/filings/0001628280-23-037927.md) | Quarterly report, period 2023-09-30 | 0001628280-23-037927 |
| 2023-11-08 | 17:02 ET | [8-K](/filings/0001628280-23-037916.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-037916 |
| 2023-10-27 | 17:15 ET | [8-K](/filings/0001193125-23-265256.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-23-265256 |
| 2023-10-03 | 06:55 ET | [8-K](/filings/0001628280-23-033551.md) | 8.01 Other events | 0001628280-23-033551 |

Page 1 of 3. [Older](/companies/dna/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:07 ET. No prices; not investment advice.